Virology
Prevalence of human polyomaviruses
By Vincent Racaniello
While immunosuppressive therapy can ameliorate a variety of diseases, one unfortunate side effect of the treatment is that it may lead to pathogenic infections by viruses which would otherwise be benign. An example is the brain infection PML which occurs when immunosuppression leads to replication of the polyomavirus JC. How ...
Polyomavirus JC, multiple sclerosis, Tysabri, and an anti-malaria drug
By Vincent Racaniello
Biogen has announced that an anti-malaria compound may be useful for treating a brain infection, progressive multifocal leukoencephalopathy (PML), that is an adverse effect of the company's multiple sclerosis/Crohn's disease drug Tysabri. How does JC virus fit into this story? Tysabri is the trade name for Natalizumab, a monoclonal antibody against ...
Poliovirus vaccine litigation
By Vincent Racaniello
The oral poliovirus vaccine strains (OPV) developed by Albert Sabin were licensed in the United States in 1962, and over the next 37 years immunization with these vaccines lead to the eradication of poliomyelitis in this country. During that period, the vaccine was responsible for 5-10 cases of poliomyelitis each ...
TWiV #25: Viral evolution
By Vincent Racaniello
In episode #25 of the podcast This Week in Virology, Vincent, Alan, and Luis Villarreal talk about rabies in Viet Nam and Angola, needle-stick infections with ebolavirus and West Nile virus, and viral evolution. Click the arrow above to play, or right-click to download TWiV #25 or subscribe in iTunes ...
The abundant and diverse viruses of the seas
By Vincent Racaniello
What is the most abundant biological entity in the oceans? Viruses, of course! The quantity and diversity of viruses in the seas are staggering. Each milliliter of ocean water contains several million virus particles - a global total of 1030 virions! If lined up end to end, they would stretch ...
